UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
78.98 -0.02 (-0.03%) GOLD FUTURES
2,312.10 +1.10 (+0.05%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
46,898.04 +1,115.52 (+2.44%)
Carl Zeiss Meditec AG (AFX.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 05:15PM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 8.86B |
| Enterprise value | 9.01B |
| Trailing P/E | 32.29 |
| Forward P/E | 33.11 |
| PEG ratio (5-yr expected) | 3.67 |
| Price/sales (ttm) | 4.27 |
| Price/book (mrq) | 4.15 |
| Enterprise value/revenue | 4.30 |
| Enterprise value/EBITDA | 21.94 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.90 |
| 52-week change 3 | -16.58% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 123.00 |
| 52-week low 3 | 73.18 |
| 50-day moving average 3 | 110.93 |
| 200-day moving average 3 | 96.13 |
Share statistics
| Avg vol (3-month) 3 | 226 |
| Avg vol (10-day) 3 | 72 |
| Shares outstanding 5 | 89.44M |
| Implied shares outstanding 6 | 90.61M |
| Float 8 | 36.41M |
| % held by insiders 1 | 59.14% |
| % held by institutions 1 | 24.31% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 1.1 |
| Forward annual dividend yield 4 | 1.10% |
| Trailing annual dividend rate 3 | 1.10 |
| Trailing annual dividend yield 3 | 1.10% |
| 5-year average dividend yield 4 | 0.96 |
| Payout ratio 4 | 35.48% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 22 Mar 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Sept 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 13.22% |
| Operating margin (ttm) | 9.22% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | 13.24% |
Income statement
| Revenue (ttm) | 2.09B |
| Revenue per share (ttm) | 23.44 |
| Quarterly revenue growth (yoy) | 1.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 357.67M |
| Net income avi to common (ttm) | 276.8M |
| Diluted EPS (ttm) | 3.10 |
| Quarterly earnings growth (yoy) | -26.70% |
Balance sheet
| Total cash (mrq) | 10.6M |
| Total cash per share (mrq) | 0.12 |
| Total debt (mrq) | 155.7M |
| Total debt/equity (mrq) | 7.16% |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | 24.14 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.